- Roger E. Susi, CEO, President and Chairman of IRadimed, reported sales of common stock on March 23, 2026 and March 24, 2026.
- The filing shows 2,950 shares were sold at a weighted average price of USD 99.58 and 750 shares were sold at a weighted average price of USD 100.7.
- It also reports sales of 1,300 shares at a weighted average price of USD 102.02 and 1,585 shares at a weighted average price of USD 100.03.
- Additional sales included 915 shares at a weighted average price of USD 100.71, with 2,232,500 shares held indirectly afterward through the Phillip Susi 2008 Dynasty Trust.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. IRadimed Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001613801-26-000018), on March 25, 2026, and is solely responsible for the information contained therein.
Comments